Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study. (2018). Biomolecules and Biomedicine, 18(2), 185-190. https://doi.org/10.17305/bjbms.2017.2279